Functional efficacy of glatiramer acetate treatment for laser-induced retinal damage in rats

被引:6
作者
Belokopytov, Mark [1 ]
Ben-Shlomo, Gil [2 ]
Rosner, Mordechai [1 ]
Belkin, Michael [1 ]
Dubinski, Galina [1 ]
Epstein, Yoram [1 ]
Ofri, Ron [2 ]
机构
[1] Tel Aviv Univ, Goldschleger Eye Res Inst, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[2] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel
关键词
electroretinogram; laser; neuroprotection; retinal injury; wound healing;
D O I
10.1002/lsm.20610
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Objectives: To functionally evaluate the efficacy of glatiramer acetate (Cop-1) as a neuroprotective treatment for laser-induced retinal injuries in rats. Study Design/Materials and Methods: Using standard lasering and flash ERG techniques, we evaluated the effect of photocoagulation and of Cop-1 treatment on retinal function 3, 20, and 60 days after covering one-half of the retina with of 23 rats with argon laser lesions. Results: Significant neuroprotective effects of Cop-1 treatment on functional recovery were observed 20 and 60 days after retinal photocoagulation. Two months post-lasering, the amplitude of electroretinographic signals in lasered eyes (mean +/- SEM) was 99.5 +/- 10.2% of that of intact eyes in the Cop-l-treated group and 85.8 +/- 5.5% in the untreated lasered control group (P<0.05). Conclusions: Cop-1 immunization in rats is neuroprotective against laser-induced injuries to the outer retina and improves functional recovery of the injured retina. Studies have documented effective neuroprotective treatment after laser damage to myelinated neurons, but this is the first report of neuroprotection of nonmyelinated neurons.
引用
收藏
页码:196 / 201
页数:6
相关论文
共 51 条
[41]   PROGRESSIVE ENLARGEMENT OF LASER SCARS FOLLOWING GRID LASER PHOTOCOAGULATION FOR DIFFUSE DIABETIC MACULAR EDEMA [J].
SCHATZ, H ;
MADEIRA, D ;
MCDONALD, R ;
JOHNSON, RN .
ARCHIVES OF OPHTHALMOLOGY, 1991, 109 (11) :1549-1551
[42]   Immune-related mechanisms participating in resistance and susceptibility to glutamate toxicity [J].
Schori, H ;
Yoles, E ;
Wheeler, LA ;
Raveh, T ;
Kimchi, A ;
Schwartz, M .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 16 (04) :557-564
[43]   T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system [J].
Schori, H ;
Yoles, E ;
Schwartz, M .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 119 (02) :199-204
[44]   Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma [J].
Schori, H ;
Kipnis, J ;
Yoles, E ;
WoldeMussie, E ;
Ruiz, G ;
Wheeler, LA ;
Schwartz, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3398-3403
[45]   Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases [J].
Schwartz, M ;
Kipnis, J .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 233 (1-2) :163-166
[46]   Autoimmunity can benefit self-maintenance [J].
Schwartz, M ;
Cohen, IR .
IMMUNOLOGY TODAY, 2000, 21 (06) :265-268
[49]  
Solberg Y, 1997, INVEST OPHTH VIS SCI, V38, P1380
[50]   Degeneration of spared axons following partial white matter lesion: Implications for optic nerve neuropathies [J].
Yoles, E ;
Schwartz, M .
EXPERIMENTAL NEUROLOGY, 1998, 153 (01) :1-7